Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
Railways on Saturday successfully tested crowd control measures at New Delhi Railway Station. Und
The 18th edition of the Indian Premier League (IPL) can start on 22 March. The opening match of I
Dangerous cyclonic storm Remal reached West Bengal and Bangladesh on Sunday night with a speed of
The meeting between President Donald Trump and PM Narendra Modi has prepared a blueprint for the
US President Donald Trump is surrounded in his own country over tariffs. His own party's Republic
Aditya Dhar's directorial venture 'Dhurandhar' is currently making waves everywhere. The film is
Actress Tamannaah Bhatia and actor Vijay Verma were dating each other for a long time. Both were
Health facilities in Uttar Pradesh will get wings. A provision of Rs 50550.42 crore has been made
At least 276 Covid-19 cases were reported in India during the last 24 hours, taking the total num
Keeping in mind that the sentiments of crores of devotees of Tirupati are being affected by the a
